IP Library Granted Patent US 7,820,383
Granted Patent B2
US 7,820,383 · App. 11/283,168 · Granted Oct 26, 2010

Method for diagnosing myocardial infarction

Assignee: Interleukin Genetics, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,820,383
App. No.
11/283,168
Granted
Oct 26, 2010
Kind
B2
Abstract

The kits and methods of the present invention relate to the diagnosis of cardiovascular disorders. In one aspect, the invention discloses a method and a kit for determining whether a subject has a fragile plaque disorder. In one aspect, the invention discloses a method and a kit for determining whether the subject has an occlusive disorder. In one aspect, the invention discloses a method and a kit for determining whether the subject has a restenosis disorder. Other methods of the present invention relate to the selection of therapeutics for a patient with a cardiovascular disease.

Claims (2)

1. A method for determining a human male subject's predisposition to increased risk for myocardial infarction at or before the age of 55, comprising detecting an allelic pattern of two copies of IL-1B (−511) allele 1, an IL-1B (+3954) allele 2, and an IL-1A (+4845) allele 2; wherein the presence of said pattern indicates that said subject is predisposed to myocardial infarction at or before the age of 55.

2. The method of claim 1 , wherein said subject has increased expression of IL-1β and C-reactive protein.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Nov 27, 2017
From: HORIZON TECHNOLOGY FINANCE CORPORATION
To: INTERLEUKIN GENETICS INC.
Reel/Frame 044511/0428 →
RELEASE OF SECURITY INTEREST Recorded Nov 27, 2017
From: HORIZON TECHNOLOGY FINANCE CORPORATION
To: INTERLEUKIN GENETICS, INC.
Reel/Frame 044511/0467 →
SECURITY INTEREST Recorded Apr 13, 2017
From: INTERLEUKIN GENETICS, INC.
To: HORIZON TECHNOLOGY FINANCE CORPORATION
Reel/Frame 042001/0331 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 1, 2010
From: UNIVERSITY OF SHEFFIELD
To: INTERLEUKIN GENETICS, INC.
Reel/Frame 025079/0840 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 24, 2010
From: KORNMAN, KENNETH; MARTINEZ, KATHERINE
To: INTERLEUKIN GENETICS, INC.
Reel/Frame 025040/0860 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 24, 2010
From: FRANCIS, SHEILA E.; CROSSMAN, DAVID C.; DUFF, GORDON W.
To: UNIVERSITY OF SHEFFIELD
Reel/Frame 025040/0870 →
Continuity (5)
Continuation In Part 1032036000 · Dec 13, 2002
Continuation 0943135200 · Nov 1, 1999
Continuation In Part 0932039500 · May 26, 1999
Continuation In Part 0881345600 · Mar 10, 1997
Related Publication 20060252055A1 · Nov 9, 2006